ArticleHeliyon2020

QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2.

Abdullahi Bello Umar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.